A concise review of VEGF, PDGF, FGF, Notch, angiopoietin, and HGF signalling in tumor angiogenesis with a focus on alternative approaches and future directions
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A concise review of VEGF, PDGF, FGF, Notch, angiopoietin, and HGF signalling in tumor angiogenesis with a focus on alternative approaches and future directions
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume 221, Issue -, Pages 1428-1438
Publisher
Elsevier BV
Online
2022-09-17
DOI
10.1016/j.ijbiomac.2022.09.129
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and efficacy review of aflibercept for the treatment of metastatic colorectal cancer
- (2022) David K. Lau et al. Expert Opinion On Drug Safety
- VEGF-Independent Angiogenic Factors: Beyond VEGF/VEGFR2 Signaling
- (2022) Ryoji Eguchi et al. JOURNAL OF VASCULAR RESEARCH
- Signaling pathways modulated by miRNAs in breast cancer angiogenesis and new therapeutics
- (2022) Bashdar Mahmud Hussen et al. PATHOLOGY RESEARCH AND PRACTICE
- LncRNAs and the Angiogenic Switch in Cancer: Clinical Significance and Therapeutic Opportunities
- (2022) Peace Mabeta et al. Genes
- Tumour generated exosomal miRNAs: A major player in tumour angiogenesis
- (2022) V.B. Sameer Kumar et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Angioregulatory role of miRNAs and exosomal miRNAs in glioblastoma pathogenesis
- (2022) Behnaz Bouzari et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer combination therapies by angiogenesis inhibitors; a comprehensive review
- (2022) Mohammad Javed Ansari et al. Cell Communication and Signaling
- Blockade of Cycloxygenase-2 ameliorates sepsis induced immune-suppression by regulating myeloid-derived suppressor cells
- (2022) Jiajun Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review
- (2022) Xiang Zou et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Role of macrophages in tumor progression and therapy (Review)
- (2022) Yiwei Xu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Cancer Angiogenesis and Opportunity of Influence on Tumor by Changing Vascularization
- (2022) Igor Maiborodin et al. Journal of Personalized Medicine
- Non-coding RNAs in lung cancer: emerging regulators of angiogenesis
- (2022) Yajie Liao et al. Journal of Translational Medicine
- Anti-Jagged-1 immunotherapy in cancer
- (2022) Joanna Pancewicz et al. Advances in Medical Sciences
- Epigenetic Alterations in Renal Cell Cancer With TKIs Resistance: From Mechanisms to Clinical Applications
- (2021) Qinhan Li et al. Frontiers in Genetics
- Monotherapy and Combination Therapy Using Anti‐Angiogenic Nanoagents to Fight Cancer
- (2021) Pingping Liang et al. ADVANCED MATERIALS
- Current treatment and recent progress in gastric cancer
- (2021) Smita S. Joshi et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data
- (2021) Antonia M. Joussen et al. EYE
- Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective
- (2021) Abdellah Akil et al. Frontiers in Cell and Developmental Biology
- MicroRNAs and angiogenesis: a new era for the management of colorectal cancer
- (2021) Yufei Tang et al. Cancer Cell International
- MicroRNA-432-5p regulates sprouting and intussusceptive angiogenesis in osteosarcoma microenvironment by targeting PDGFB
- (2021) Selvaraj Vimalraj et al. LABORATORY INVESTIGATION
- The HIF1α-PDGFD-PDGFRα axis controls glioblastoma growth at normoxia/mild-hypoxia and confers sensitivity to targeted therapy by echinomycin
- (2021) Gong Peng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Neoadjuvant Treatment with Angiogenesis‐Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study
- (2021) F.J. Sherida H. Woei‐A‐Jin et al. ONCOLOGIST
- Stability assessment of FDA‐approved ramucirumab monoclonal antibody; validated SE‐HPLC method for degradation pattern evaluation
- (2021) Sara Hesham Abdelghaffar et al. BIOMEDICAL CHROMATOGRAPHY
- CRISPR/Cas9 in cancer therapy: A review with a special focus on tumor angiogenesis
- (2021) Krishnasamy naidu gopal Hariprabu et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- LncRNA MALAT1 Promotes Tumor Angiogenesis by Regulating MicroRNA-150-5p/VEGFA Signaling in Osteosarcoma: In-Vitro and In-Vivo Analyses
- (2021) Selvaraj Vimalraj et al. Frontiers in Oncology
- Antiangiogenic Properties of Axitinib versus Sorafenib Following Sunitinib Resistance in Human Endothelial Cells—A View towards Second Line Renal Cell Carcinoma Treatment
- (2021) Eva Juengel et al. Biomedicines
- Knockout of Hepatocyte Growth Factor by CRISPR/Cas9 System Induces Apoptosis in Hepatocellular Carcinoma Cells
- (2021) Han Ki Lee et al. Journal of Personalized Medicine
- Vascular mimicry: changing the therapeutic paradigms in cancer
- (2020) Nazila Fathi Maroufi et al. MOLECULAR BIOLOGY REPORTS
- Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook
- (2020) Josep Garcia et al. CANCER TREATMENT REVIEWS
- The roles of tumor-associated macrophages in tumor angiogenesis and metastasis
- (2020) Luo-Qin Fu et al. CELLULAR IMMUNOLOGY
- Therapeutic paradigm of dual targeting VEGF and PDGF for effectively treating FGF-2 off-target tumors
- (2020) Kayoko Hosaka et al. Nature Communications
- Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy
- (2020) Cátia Rebelo de Almeida et al. Communications Biology
- Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers
- (2020) Wioletta Olejarz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Knockout of EGFL6 by CRISPR/Cas9 Mediated Inhibition of Tumor Angiogenesis in Ovarian Cancer
- (2020) Wenhui Zhu et al. Frontiers in Oncology
- LncRNA EPIC1 promotes tumor angiogenesis via activating the Ang2/Tie2 axis in non-small cell lung cancer
- (2020) Yanjiao Hou et al. LIFE SCIENCES
- Vessel co-option in cancer
- (2019) Elizabeth A. Kuczynski et al. Nature Reviews Clinical Oncology
- VON HIPPEL–LINDAU DISEASE
- (2019) Mary E. Aronow et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases
- (2019) Gregg B. Fields Frontiers in Immunology
- HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers
- (2019) Fatemeh Moosavi et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- LncRNA DANCR promotes tumor growth and angiogenesis in ovarian cancer through direct targeting of miR‐145
- (2019) Xiaojuan Lin et al. MOLECULAR CARCINOGENESIS
- Biogenic gold nanoparticles synthesis mediated by Mangifera indica seed aqueous extracts exhibits antibacterial, anticancer and anti-angiogenic properties
- (2018) Selvaraj Vimalraj et al. BIOMEDICINE & PHARMACOTHERAPY
- Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors
- (2018) David M. Hyman et al. CLINICAL CANCER RESEARCH
- Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
- (2018) Yoshiro Itatani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Stomatitis and VEGFR-Tyrosine Kinase Inhibitors (VR-TKIs): A Review of Current Literature in 4369 Patients
- (2018) Claudia Arena et al. Biomed Research International
- Models to investigate intussusceptive angiogenesis: A special note on CRISPR/Cas9 based system in zebrafish
- (2018) Selvaraj Vimalraj et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Classical VEGF, Notch and Ang signalling in cancer angiogenesis, alternative approaches and future directions
- (2017) Nunzia Caporarello et al. Molecular Medicine Reports
- Genome editing abrogates angiogenesis in vivo
- (2017) Xionggao Huang et al. Nature Communications
- VEGF/NRP-1 axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin
- (2016) Minna Luo et al. CANCER LETTERS
- Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality
- (2016) Simon Lord et al. CURRENT DRUG TARGETS
- Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature
- (2015) Elena I. Deryugina et al. MATRIX BIOLOGY
- Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor
- (2015) Y. Zhao et al. ONCOLOGIST
- Neuropilin regulation of angiogenesis: Figure 1
- (2014) Anastasia Lampropoulou et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
- (2014) Martin Reck et al. LANCET ONCOLOGY
- Pazopanib a tyrosine kinase inhibitor with strong anti-angiogenetic activity: A new treatment for metastatic soft tissue sarcoma
- (2013) Girolamo Ranieri et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Directed Evolution of an Angiopoietin-2 Ligand Trap by Somatic Hypermutation and Cell Surface Display
- (2013) Nicholas P. J. Brindle et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dll4-Notch signaling in regulation of tumor angiogenesis
- (2013) Zhaoguo Liu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- MET and VEGF: synergistic targets in castration-resistant prostate cancer
- (2011) Dana T. Aftab et al. Clinical & Translational Oncology
- Involvement of COX-2/PGE2 signalling in hypoxia-induced angiogenic response in endothelial cells
- (2011) Lixing Zhao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Extracellular Matrix Degradation and Remodeling in Development and Disease
- (2011) P. Lu et al. Cold Spring Harbor Perspectives in Biology
- Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models
- (2010) Chunhua Lu et al. CANCER BIOLOGY & THERAPY
- Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
- (2009) Kristy J. Gotink et al. ANGIOGENESIS
- Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancer
- (2009) Robert S. Kerbel BREAST
- R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways
- (2008) Yihai Cao et al. JOURNAL OF MOLECULAR MEDICINE-JMM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now